billHR4544Event Thursday, May 21, 2026Analyzed

American Access to Banking Act

Neutral

Summary

H.R. 4544 is a procedural early-stage bill that directs federal banking agencies to review and streamline new bank formation processes. It authorizes zero spending, creates no direct financial impact on any publicly traded company, and remains on the Union Calendar with no near-term passage probability.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.H.R. 4544 is a procedural bill with zero authorized spending and no direct market impact.
  • 2.The bill remains in early legislative stages with no near-term passage probability.
  • 3.No publicly traded companies are directly affected; the bill's impact on bank formation is administrative and long-term.

Market Implications

The bill has no measurable impact on financial sector stocks. Morgan Stanley ($MS) trades at $212.33, up 9.81% over 30 days, and Wells Fargo ($WFC) at $82.17, up 6.48% over 7 days—these moves reflect broader market trends, not legislative action. No tickers warrant inclusion due to the bill's procedural nature.

Full Analysis

The American Access to Banking Act (H.R. 4544) was introduced on July 17, 2025, by Rep. Maxine Waters (D-CA) and referred to the House Committee on Financial Services. As of the event date of May 21, 2026, the bill remains in early legislative stages—referred to committee and placed on the Union Calendar. The bill requires federal banking regulators (e.g., OCC, FDIC, Fed) to review application processes for de novo banks and credit unions, designate caseworkers for applicants, and report annually for five years. It authorizes zero new spending and creates no immediate financial obligations or revenue streams for any publicly traded company. The legislative path forward requires passage through the House and Senate, which has not occurred. Given the procedural nature and lack of funding, the market impact is negligible. Real market data shows Morgan Stanley ($MS) at $212.33 (near its 52-week high of $218.3) and Wells Fargo ($WFC) at $82.17, with recent price movements driven by broader market factors, not this bill. No tickers meet the causal chain confidence gate because the bill's effects are too indirect and uncertain to link to specific company revenue or costs.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →